Publications
UBC Webinar: Biomanufacturing & Quality Control
xCellarate delivered a 2-hr webinar on the topic of Biomanufacturing & Quality Control, -Cell & Gene Therapy, recombinant proteins, MAb's, and vaccines. The October 2022 webinar was a component of the Regulatory Affairs Micro-credential Programme at UBC.
Publication in PDA JPST
-Lessons from a Pandemic
COVID-19 impact on global pharmaceutical supply chain management
Co-authored with Jose Caraballo of Bayer Pharmaceuticals
QA Compliance & GPP's in Cannabis Industry
Keystone Laboratories conference series
Speaking engagement in partnership with QnR Associates
![](https://www.google.com/images/icons/product/drive-32.png)
Foreign Manufacturing Sites
Challenges with foreign sites in NHP industry
![](https://www.google.com/images/icons/product/drive-32.png)
QA Agreements in Health Regulated Industries
Vital importance of good QA Agreements
![](https://www.google.com/images/icons/product/drive-32.png)
GEN Article
Contributing writer for numerous articles
![](https://www.google.com/images/icons/product/drive-32.png)
Genetic Engineering News articles published
1. “Artificial Tissues Target Range of Medical Conditions”, Vol.20, No. 1 Jan 2000.
2. “Challenges in Pharmacogenomics”, Vol.20, No.6 Mar 15, 2000.
3. “Animal Cloning Techniques and Technologies”, Vol.21, No.1, Jan 1, 2001.
4. “Rational Drug Design in the Post-Genomics Era”, Vol.21, No. 20, Nov 15, 2001.
5. “Contract Bio-Product Stability Testing Services”, Vol. 23, No. 6 Mar 15, 2003.
6. “Recombinant protein product production in animal species”, 2003.
7. Structure-based Drug Design, 2004
8. “Techniques in Viral Clearance Validation”, 2005.
9. Corporate Profile: “Progenitor Tackles Obstacles in Cell Therapy”, vol.25, No. 17, Oct 1 2005.
10. “Techniques for Characterizing Biologics”, Apr-May 2007 -see above for copy